Li-Tzong Chen Selected Research

Li-Tzong Chen Research Topics

Disease

101	Neoplasms (Cancer) 02/2024 - 09/2002
40	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024 - 03/2006
31	Adenocarcinoma 03/2024 - 11/2013
17	Hepatocellular Carcinoma (Hepatoma) 09/2022 - 01/2003
16	Stomach Neoplasms (Stomach Cancer) 02/2024 - 01/2002
14	Disease Progression 01/2023 - 09/2005
14	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2022 - 12/2006
14	Lymphoma (Lymphomas) 01/2020 - 06/2003
13	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 02/2022 - 08/2004
11	Carcinogenesis 02/2023 - 02/2012
11	Neoplasm Metastasis (Metastasis) 12/2022 - 12/2013
10	Biliary Tract Neoplasms (Biliary Tract Cancer) 11/2023 - 07/2015
7	Carcinoma (Carcinomatosis) 04/2019 - 07/2004
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 09/2005
6	B-Cell Lymphoma (Lymphoma, B Cell) 04/2019 - 10/2008
5	Neutropenia 10/2021 - 01/2002
5	Infections 01/2021 - 09/2005
5	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2004
5	Nasopharyngeal Carcinoma 03/2014 - 07/2002
4	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 02/2024 - 07/2009
4	Primitive Neuroectodermal Tumors (PNET) 11/2022 - 11/2017
4	Hemorrhage 09/2022 - 11/2005
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021 - 12/2016
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2019 - 10/2016
3	Melanoma (Melanoma, Malignant) 01/2023 - 10/2015
3	Fatigue 01/2023 - 02/2016
3	Cholangiocarcinoma 01/2023 - 01/2018
3	Febrile Neutropenia 01/2022 - 01/2002
3	Adenocarcinoma of Lung 01/2022 - 06/2015
3	Thrombocytopenia (Thrombopenia) 10/2021 - 05/2006
3	Fever (Fevers) 01/2020 - 05/2006
3	Necrosis 02/2017 - 07/2004
3	Hepatitis B 01/2016 - 06/2010
2	Squamous Cell Carcinoma of Head and Neck 11/2023 - 01/2023
2	Liver Diseases (Liver Disease) 09/2022 - 09/2005
2	Liver Neoplasms (Liver Cancer) 05/2022 - 07/2014
2	Splenomegaly 01/2022 - 09/2005
2	Sepsis (Septicemia) 01/2022 - 10/2021

Drug/Important Bio-Agent (IBA)

35	Gemcitabine FDA Link 03/2024 - 03/2006
34	Leucovorin (Folinic Acid)FDA Link 03/2024 - 01/2002
33	Fluorouracil (Carac)FDA LinkGeneric 03/2024 - 01/2002
23	Irinotecan (Camptosar)FDA LinkGeneric 03/2024 - 02/2016
16	Proteins (Proteins, Gene)FDA Link 02/2024 - 04/2012
14	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2004
12	Imatinib Mesylate (Gleevec)FDA Link 12/2022 - 12/2006
10	Biomarkers (Surrogate Marker)IBA 11/2023 - 06/2012
10	NivolumabIBA 10/2022 - 12/2017
10	Thalidomide (Thalomid)FDA Link 02/2022 - 01/2003
8	Phosphotransferases (Kinase)IBA 04/2021 - 01/2008
8	Everolimus FDA Link 11/2017 - 05/2011
7	Cisplatin (Platino)FDA LinkGeneric 08/2022 - 01/2002
6	Tyrosine Kinase InhibitorsIBA 12/2022 - 01/2013
6	Anti-Bacterial Agents (Antibiotics)IBA 02/2022 - 09/2005
6	EnzymesIBA 01/2022 - 09/2016
6	Messenger RNA (mRNA)IBA 08/2017 - 04/2012
5	CateninsIBA 02/2022 - 01/2019
5	Capecitabine (Xeloda)FDA Link 01/2022 - 07/2011
5	ErbB Receptors (EGF Receptor)IBA 01/2022 - 02/2012
4	AntigensIBA 01/2023 - 10/2013
4	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2022 - 11/2017
4	Sorafenib (BAY 43-9006)FDA Link 05/2022 - 12/2013
4	Antineoplastic Agents (Antineoplastics)IBA 02/2022 - 07/2002
4	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 07/2021 - 10/2014
4	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2019 - 01/2008
4	7-hydroxy-6-methoxyphthalide (MA-1)IBA 02/2017 - 11/2011
3	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2024 - 11/2014
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 01/2021
3	ChromatinIBA 01/2022 - 08/2012
3	RamucirumabIBA 10/2021 - 10/2017
3	ADI PEG20IBA 01/2021 - 06/2013
3	Cetuximab (Erbitux)FDA Link 06/2019 - 09/2014
3	Arginine (L-Arginine)FDA Link 12/2017 - 06/2013
3	MTOR InhibitorsIBA 11/2017 - 05/2011
3	Docetaxel (Taxotere)FDA Link 01/2016 - 01/2002
3	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 11/2003
3	PlatinumIBA 01/2016 - 07/2009
3	Indicators and Reagents (Reagents)IBA 02/2014 - 04/2012
3	NF-kappa B (NF-kB)IBA 10/2008 - 09/2004
3	ParaffinIBA 01/2008 - 09/2004
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2024 - 11/2022
2	Peptides (Polypeptides)IBA 01/2024 - 04/2004
2	durvalumabIBA 11/2023 - 08/2022
2	regorafenibIBA 02/2023 - 07/2017
2	Small Interfering RNA (siRNA)IBA 01/2023 - 11/2017
2	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2023 - 01/2018
2	TensinsIBA 11/2022 - 11/2017
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 02/2022 - 03/2014
2	Semaphorins (Semaphorin)IBA 02/2022 - 01/2022
2	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2015
2	AlbuminsIBA 01/2022 - 09/2005

Therapy/Procedure

62	Therapeutics 02/2024 - 01/2004
35	Drug Therapy (Chemotherapy) 11/2023 - 06/2003
7	Radiotherapy 01/2023 - 01/2004
6	Chemoradiotherapy 11/2023 - 12/2011
4	Neoadjuvant Therapy 09/2023 - 08/2012
3	Immunotherapy 11/2023 - 11/2018
3	Adjuvant Chemotherapy 09/2023 - 01/2022
3	Salvage Therapy 01/2022 - 12/2011
3	Induction Chemotherapy 01/2022 - 12/2011
2	Gastrectomy 01/2023 - 11/2021